Postpartum Depression Clinical Trials

Find Postpartum Depression Clinical Trials Near You

Evaluating the Psychological and Physiological Impact of a Mindfulness-based Intervention on Anxiety Disorders During the Postpartum Period: A Proof of Concept Trial

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Postpartum anxiety (PPA) affects up to 20% of mothers in the first year after delivery, with mothers often reporting both psychological and physical symptoms. Present non-pharmacological interventions are effective at improving some psychological aspects of PPA such as anxiety, depressive mood, and distress. However, current interventions are not effective in improving emotion regulation (ER), something that many with PPA experience impairment in. Current interventions also seldom target the physical aspects of anxiety, such as bodily awareness - sensing and understanding internal signals in the body (e.g., sensing a fast heartbeat). There is a link between ER and bodily awareness, however psychological interventions that target both these aspects have not been investigated in the PPA population. As a result, a mind-body intervention targeting both ER and bodily awareness is needed to offer a more holistic treatment option. The purpose of the proposed study is to test the effectiveness of a 4-week mindfulness intervention on anxiety symptoms, ER, and bodily awareness in those with PPA. We will use self-report questionnaires alongside brain imaging (functional magnetic resonance imaging; fMRI) to evaluate the effectiveness. Combining both subjective and objective measures will provide greater confidence in our findings, ensuring a more comprehensive understanding of the intervention's impact. Self-report questionnaires will be administered at enrolment, immediately post-intervention, and 4 weeks post-intervention. Brain imaging will be conducted at enrolment and immediately post-intervention. We believe this intervention will lead to improvements in anxiety symptoms, ER, and bodily awareness on the questionnaires and fMRI scans. If effective, the proposed mindfulness intervention will target a broader range of psychological and physical symptoms, and reduce the negative impact of PPA on mothers and their infants in Canada and beyond.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• mothers/birthing parents 18 years and older who are between 0-12 months postpartum

• principal diagnosis of an anxiety disorder as per the Diagnostic Assessment Research Tool (DART; Schneider et al., 2022), with or without comorbid depression

• no concurrent psychological treatment

• not taking psychoactive medication or a) medications are stable in dose and type for at least 8 weeks prior to the study (as per Canadian psychiatric guidelines; McQueen et al., 2016) and b) medications remain stable throughout the study

• fluent in English, minimal grade 8 reading level.

Locations
Other Locations
Canada
Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton
RECRUITING
Hamilton
Women's Health Concerns, St. Joseph's Healthcare Hamilton
RECRUITING
Hamilton
Contact Information
Primary
Sheryl M Green, Ph.D., C.Psych
sgreen@stjosham.on.ca
905-522-1155
Backup
Zoryana Babiy, M.Sc.
babiyz@mcmaster.ca
Time Frame
Start Date: 2025-12
Estimated Completion Date: 2026-09
Participants
Target number of participants: 50
Treatments
Experimental: 4-week mindfulness intervention
No_intervention: Waitlist treatment as usual control
Related Therapeutic Areas
Sponsors
Leads: St. Joseph's Healthcare Hamilton

This content was sourced from clinicaltrials.gov